Cumberland Pharmaceuticals (CPIX) Reports Q4 Loss of $0.14

Cumberland Pharmaceuticals (NASDAQ: CPIX) reported Q4 EPS of ($0.14). Revenue for the quarter came in at $10.44 million.

For earnings history and earnings-related data on Cumberland Pharmaceuticals (CPIX) click here.

You May Also Be Interested In

• TD Cowen Starts Braveheart Bio (BRVE) at Buy
• Needham Starts AirJoule Technologies (AIRJ) at Hold
• Cloudflare (NET) Reiterated at Market Outperform by Citizens After Meeting With CFO, AI Head